ArticleFrontiers in oncology2025
Case Report: Atypical prostate cancer presentation: rectal bleeding, pain, and psoriasiform dermatitis.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Unmasking recurrent melena as the initial presentation of metastatic prostate cancer: a case report.Frontiers in oncology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate cancer is typically asymptomatic and usually diagnosed through concerted screening programs. However, in settings where there are no existing national prostate cancer screening programs, it may be picked up at the clinics in patients presenting with urinary symptoms, erectile dysfunction, and hematospermia/hematuria. Rare atypical presentations may also occur, delaying diagnosis and management. This case report discusses a 61-year-old male of Black-African descent, whose first presentation to the hospital for a condition ultimately diagnosed as metastatic prostate cancer, was due to lower gastrointestinal bleeding, rectal pain, and psoriasiform dermatitis. The patient's clinical findings included a moderate-sized (grade 2) nodular prostate on digital rectal examination (DRE), a total serum prostate-specific antigen (PSA) level of >200 ng/mL, low back bone pain, and osteoblastic lesions on lumbosacral spine X-ray. Prostate core biopsy histopathologically confirmed adenocarcinoma with a Gleason score of 4 + 4 = 8. Histopathological examination of the synchronous skin lesions revealed psoriasiform dermatitis. The patient was managed with surgical androgen deprivation therapy (ADT), followed by oral bicalutamide, dermatologist consultation, and blood transfusions. He was also scheduled for further radiotherapy and chemotherapy (to complete the multimodality prostate cancer treatment). This case highlights the importance of considering prostate cancer with atypical presentations and underscores the need for a multidisciplinary approach in managing advanced cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.